http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090110936-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-643 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52 |
| filingDate | 2008-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20090110936-A |
| titleOfInvention | Therapeutic Applications of Casal-type Serine Protease Inhibitors |
| abstract | The object of the present invention is, in the most general aspect, a casal-type serine protease inhibitor infestin or a domain thereof, which prevents the formation and / or stabilization of three-dimensional arterial or venous thrombi by interfering with the proteins involved in the activation of the so-called endogenous coagulation pathway. Or in therapeutic applications of modified casal-type serine protease inhibitors based on infestin homologues. In particular, the present invention relates to conditions or diseases associated with arterial thrombus formation, namely stroke, myocardial infarction, inflammation, complement activation, fibrinolysis, angiogenesis and / or hypotonic shock, edema including hereditary angioedema, bacterial infection, arthritis, Use of said casal-type serine protease inhibitors or fragments or modified casal-type serine protease inhibitors in the treatment or prevention of diseases associated with pathological kinin formation such as pancreatitis or joint gout, disseminated intravascular coagulation (DIC) and sepsis. It is about. |
| priorityDate | 2007-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2140.